EBA
ROIV icon

Eagle Bay Advisors’s Roivant Sciences ROIV Stock Holding History

Eagle Bay Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-506
Closed -$5.99K – 775
2024
Q4 		$5.99K Hold
506
– – ﹤0.01% 668
2024
Q3 		$5.84K Hold
506
– – ﹤0.01% 946
2024
Q2 		$5.35K Hold
506
– – ﹤0.01% 686
2024
Q1 		$5.33K Hold
506
– – ﹤0.01% 708
2023
Q4 		$5.68K Hold
506
– – ﹤0.01% 616
2023
Q3 		$5.91K Hold
506
– – ﹤0.01% 659
2023
Q2 		$5.1K Hold
506
– – ﹤0.01% 666
2023
Q1 		$3.73K Hold
506
– – ﹤0.01% 701
2022
Q4 		$4.04K Hold
506
– – ﹤0.01% 697
2022
Q3 		$2K Hold
506
– – ﹤0.01% 776
2022
Q2 		$2.06K Buy
+506
New +$2.01K ﹤0.01% 822
2022
Q1 		– Sell
-506
Closed -$5K – 829
2021
Q4 		$5K Buy
+506
New +$4.21K ﹤0.01% 803

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Eagle Bay Advisors's ROIV Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Roivant Sciences (ROIV) in Q1 2025, closing a stake of 506 shares — an estimated $5.99K sold.

Eagle Bay Advisors first reported a position in ROIV in Q4 2021 and held it in 12 quarters. The position peaked at $5.99K in Q4 2024. 312 funds tracked by Wall St. Rank hold ROIV as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Roivant Sciences position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 506 Roivant Sciences shares in Q1 2025, an estimated $5.99K.
  • Eagle Bay Advisors first reported a position in Roivant Sciences in Q4 2021 and held it in 12 quarters.
  • Eagle Bay Advisors's Roivant Sciences position peaked at $5.99K in Q4 2024.
  • 312 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.